For the 5-year follow-up model, essential features included age, renin-angiotensin system medications, hyperlipidemia, triglyceride levels, CCI score, gender, antithrombotic drugs, stroke history, hypertension, and calcium-channel blockers. This evidence concerns the gene REN and Hypertension.